Comparison of viral vectors for transduction of primary human acute myeloid leukemia (AML) cells.

被引：0
|
作者：
Barlett, AL
Marangolo, M
Bailey, C
Ginn, SL
Bendall, LJ
Bradstock, KF
Rasko, J
Gottlieb, DJ
机构：
[1] Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW, Australia
[2] Centenary Inst Canc Med & Cell Biol, Gene Therapy Res Unit, Sydney, NSW, Australia
[3] Childrens Hosp, Gene Therapy Unit, Sydney, NSW, Australia
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5544
引用
收藏
页码：489B / 490B
页数：2
相关论文
共 50 条
  • [41] The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status
    G Tsykunova
    H Reikvam
    R Hovland
    Ø Bruserud
    Leukemia, 2012, 26 : 557 - 559
  • [42] Human acute myeloid leukemia stem cells
    Hope, KJ
    Jin, LQ
    Dick, JE
    ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (06) : 507 - 514
  • [43] The mTOR inhibitor rapamycin inhibits drug transport in multidrug resistant cell lines and in acute myeloid leukemia (AML) cells.
    Pawarode, A
    O'Loughlin, KL
    Cuviello, NW
    Greco, WR
    Ford, LA
    Minderman, H
    Baer, MR
    BLOOD, 2005, 106 (11) : 435A - 435A
  • [44] PC-SPES decreases proliferation and induce differentiation of human acute myeloid leukemia cells.
    Ikezoe, T
    Chen, S
    Asou, H
    Taguchi, H
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 123A - 123A
  • [45] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [46] Mylotarg in the therapy of acute myeloid leukemia (AML).
    Weber-Nordt, RM
    Lenze, A
    Gottschling, S
    Steiger, S
    Ho, AD
    BLOOD, 2001, 98 (11) : 225B - 225B
  • [47] ACUTE MYELOID LEUKEMIA (AML)-PROGRESS AND PROMISES
    Kantarjian, Hagop
    LEUKEMIA RESEARCH, 2016, 49 : S2 - S3
  • [48] New agents in acute myeloid leukemia (AML)
    Park, Silvia
    Cho, Byung Sik
    Kim, Hee-Je
    BLOOD RESEARCH, 2020, 55 : 14 - 18
  • [49] Chromosomal rearrangements in acute myeloid leukemia (AML)
    Belloni, E.
    Trubia, M.
    Gasparini, P.
    Micucci, C.
    Tapinassi, C.
    Confalonieri, S.
    Nuciforo, P.
    Martino, B.
    Lo-Coco, F.
    Di Fiore, P. P.
    Pelicci, P. G.
    ECANCERMEDICALSCIENCE, 2010, 4
  • [50] THERAPEUTIC TARGETS FOR ACUTE MYELOID LEUKEMIA (AML)
    Sorbera, L. A.
    Verges, C.
    Dulsat, C.
    DRUGS OF THE FUTURE, 2009, 34 (01) : 67 - 77
12345